Evidence map›Paper›PMID 29898899›Full record

ArticleGenome research2018

Linking transcriptional and genetic tumor heterogeneity through allele analysis of single-cell RNA-seq data.

Jean Fan, Hae-Ock Lee, Soohyun Lee, Da-Eun Ryu, Semin Lee, Catherine Xue, Seok Jin Kim, Kihyun Kim, Nikolaos Barkas, Peter J Park and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 143 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
143citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

143 citing papers in PubMed, 1 synthesis or guideline pooled it, 259 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Multiomic, Histologic, and scRNA-seq Profiling of Pleural Mesothelioma Reveals Negative Prognosis Associated With a Novel Uncommitted Molecular Phenotype.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2026
    Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

83 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Jean Fan *Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.ORCID 0000-0002-0212-5451
Hae-Ock Lee *Samsung Genome Institute, Samsung Medical Center/Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.
Soohyun LeeDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Da-Eun RyuSamsung Genome Institute, Samsung Medical Center/Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.
Semin LeeDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Catherine XueDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Seok Jin KimDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, 06351, Korea.
Kihyun KimDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, 06351, Korea.
Nikolaos BarkasDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Peter J ParkDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center/Sungkyunkwan University School of Medicine, Seoul, 06351, Korea.
Peter V KharchenkoDepartment of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts 02115, USA.
Harvard University · USSamsung Medical Center · KR

Funding

Statistical methods for analysis of single-cell variabilityR01HL131768 · NHLBI · HARVARD MEDICAL SCHOOL · PI KHARCHENKO, PETER V · 2015 to 2019
$2.4M
Statistical Methods for Characterizing Tumor Heterogeneity at the Single Cell LevelF99CA222750 · NCI · HARVARD UNIVERSITY · PI FAN, JEAN · 2017 to 2017
$34k
NCI NIH HHS F99 CA222750NHLBI NIH HHS R01 HL131768
6 · The paper itself

Abstract

Characterization of intratumoral heterogeneity is critical to cancer therapy, as the presence of phenotypically diverse cell populations commonly fuels relapse and resistance to treatment. Although genetic variation is a well-studied source of intratumoral heterogeneity, the functional impact of most genetic alterations remains unclear. Even less understood is the relative importance of other factors influencing heterogeneity, such as epigenetic state or tumor microenvironment. To investigate the relationship between genetic and transcriptional heterogeneity in a context of cancer progression, we devised a computational approach called HoneyBADGER to identify copy number variation and loss of heterozygosity in individual cells from single-cell RNA-sequencing data. By integrating allele and normalized expression information, HoneyBADGER is able to identify and infer the presence of subclone-specific alterations in individual cells and reconstruct the underlying subclonal architecture. By examining several tumor types, we show that HoneyBADGER is effective at identifying deletions, amplifications, and copy-neutral loss-of-heterozygosity events and is capable of robustly identifying subclonal focal alterations as small as 10 megabases. We further apply HoneyBADGER to analyze single cells from a progressive multiple myeloma patient to identify major genetic subclones that exhibit distinct transcriptional signatures relevant to cancer progression. Other prominent transcriptional subpopulations within these tumors did not line up with the genetic subclonal structure and were likely driven by alternative, nonclonal mechanisms. These results highlight the need for integrative analysis to understand the molecular and phenotypic heterogeneity in cancer.

Indexed as

Genetic HeterogeneityTranscription, GeneticAllelesComputational BiologyHigh-Throughput Nucleotide SequencingHumansMultiple MyelomaMutationNeoplasmsPolymorphism, Single NucleotideSingle-Cell Analysis

Identifiers

PMID29898899
PMCPMC6071640
OpenAlexW2807848287

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.